Trademark: 88604388
Word
AIM IMMUNOTECH
Status Date
Wednesday, August 9, 2023
Filing Date
Wednesday, September 4, 2019
Published for Opposition
Tuesday, January 7, 2020
5 Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and ME/CFS; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; Interferons; Parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; Pharmaceutical products, namely, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and ME/CFS; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription
42 Pharmaceutical research and development; Pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and ME/CFS
The mark consists of a design of two curves with four horizontal lines between them, with the words "AIM ImmunoTech" to the right of the design and the word "AIM" above the word "ImmunoTech".
AIM IMMUNO TECH
Color is not claimed as a feature of the mark.
Feb 9, 2024
Teas Response To Office Action Received
Feb 9, 2024
Teas Response To Office Action Received
Nov 9, 2023
Application Extension Granted/Receipt Provided
Nov 9, 2023
Application Extension To Response Period - Received
Aug 9, 2023
Notification Of Non-Final Action E-Mailed
Aug 9, 2023
Non-Final Action E-Mailed
Aug 9, 2023
Su - Non-Final Action - Written
Jul 19, 2023
Statement Of Use Processing Complete
Jun 23, 2023
Use Amendment Filed
Jul 19, 2023
Case Assigned To Intent To Use Paralegal
Jun 23, 2023
Teas Statement Of Use Received
May 4, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2023
Sou Extension 3 Granted
May 2, 2023
Sou Extension 3 Filed
May 2, 2023
Sou Teas Extension Received
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 2 Granted
Nov 2, 2022
Sou Extension 2 Filed
Nov 2, 2022
Sou Teas Extension Received
May 4, 2022
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Sou Extension 1 Granted
May 2, 2022
Sou Extension 1 Filed
May 2, 2022
Sou Teas Extension Received
Nov 2, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 22, 2021
Ttab Release Case To Trademarks
Sep 22, 2021
Opposition Terminated No. 999999
Sep 22, 2021
Opposition Dismissed No. 999999
Jul 23, 2020
Assigned To Examiner
Jul 6, 2020
Opposition Instituted No. 999999
Jan 9, 2020
Extension Of Time To Oppose Received
Jan 7, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 7, 2020
Published For Opposition
Dec 18, 2019
Notification Of Notice Of Publication E-Mailed
Dec 3, 2019
Approved For Pub - Principal Register
Nov 22, 2019
Assigned To Examiner
Sep 17, 2019
Notice Of Design Search Code E-Mailed
Sep 16, 2019
New Application Office Supplied Data Entered
Sep 7, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
